Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 2349817, 11 pages
http://dx.doi.org/10.1155/2016/2349817
Review Article

Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase

1Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Centre, Clayton, VIC 3168, Australia
2Department of Nephrology, Monash Health, Clayton, VIC 3168, Australia

Received 11 October 2015; Accepted 21 December 2015

Academic Editor: Carlos Rosales

Copyright © 2016 Dragana Odobasic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. N. Mayadas, X. Cullere, and C. A. Lowell, “The multifaceted functions of neutrophils,” Annual Review of Pathology: Mechanisms of Disease, vol. 9, pp. 181–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Schreiber and R. Kettritz, “The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis,” Journal of Leukocyte Biology, vol. 94, no. 4, pp. 623–631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-W. Yang, B. S. I. Strong, M. J. Miller, and E. R. Unanue, “Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants,” Journal of Immunology, vol. 185, no. 5, pp. 2927–2934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Agner, “Verdoperoxidase. A ferment isolated from leukocytes,” Acta Chemica Scandinavica, vol. 2, supplement 8, pp. 1–62, 1941. View at Google Scholar
  5. J. Schultz and K. Kaminker, “Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization,” Archives of Biochemistry and Biophysics, vol. 96, no. 3, pp. 465–467, 1962. View at Publisher · View at Google Scholar · View at Scopus
  6. P. G. Rausch and T. G. Moore, “Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison,” Blood, vol. 46, no. 6, pp. 913–919, 1975. View at Google Scholar · View at Scopus
  7. A. Bos, R. Wever, and D. Roos, “Characterization and quantification of the peroxidase in human monocytes,” Biochimica et Biophysica Acta, vol. 525, no. 1, pp. 37–44, 1978. View at Publisher · View at Google Scholar · View at Scopus
  8. B. S. van der Veen, M. P. de Winther, and P. Heeringa, “Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease,” Antioxidants & Redox Signaling, vol. 11, no. 11, pp. 2899–2937, 2009. View at Publisher · View at Google Scholar
  9. K. E. Brown, E. M. Brunt, and J. W. Heinecke, “Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver,” American Journal of Pathology, vol. 159, no. 6, pp. 2081–2088, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. R. Rodrigues, D. Rodriguez, M. Russo, and A. Campa, “Macrophage activation includes high intracellular myeloperoxidase activity,” Biochemical and Biophysical Research Communications, vol. 292, no. 4, pp. 869–873, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. M. Nagra, B. Becher, W. W. Tourtellotte et al., “Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis,” Journal of Neuroimmunology, vol. 78, no. 1-2, pp. 97–107, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Malle, G. Waeg, R. Schreiber, E. F. Gröne, W. Sattler, and H.-J. Gröne, “Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins,” European Journal of Biochemistry, vol. 267, no. 14, pp. 4495–4503, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-L. Brennan, A. Gaur, A. Pahuja, A. J. Lusis, and W. F. Reynolds, “Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 112, no. 1-2, pp. 97–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. O'Sullivan, C. Y. Lo, S. A. Summers et al., “Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis,” Kidney International, vol. 88, no. 5, pp. 1030–1046, 2015. View at Publisher · View at Google Scholar
  15. V. L. Shepherd and J. R. Hoidal, “Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor,” American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 4, pp. 335–340, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sugiyama, Y. Okada, G. K. Sukhova, R. Virmani, J. W. Heinecke, and P. Libby, “Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes,” The American Journal of Pathology, vol. 158, no. 3, pp. 879–891, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Hansson, I. Olsson, and W. M. Nauseef, “Biosynthesis, processing, and sorting of human myeloperoxidase,” Archives of Biochemistry and Biophysics, vol. 445, no. 2, pp. 214–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Tobler, C. W. Miller, K. R. Johnson, M. E. Selsted, G. Rovera, and H. P. Koeffler, “Regulation of gene expression of myeloperoxidase during myeloid differentiation,” Journal of Cellular Physiology, vol. 136, no. 2, pp. 215–225, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. W. M. Nauseef, S. J. McCormick, and M. Goedken, “Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase,” The Journal of Biological Chemistry, vol. 273, no. 12, pp. 7107–7111, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shafran and S. Lyslova, “Purification and properties of myeloperoxidase from mice leukocytes,” Voprosy Meditsinskoĭ Khimii, vol. 21, pp. 629–633, 1975. View at Google Scholar
  21. D. Odobasic, A. R. Kitching, Y. Yang et al., “Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function,” Blood, vol. 121, no. 20, pp. 4195–4204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Dang, G. M. Lowe, S. W. Edwards, and D. W. Galvani, “The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils,” Leukemia Research, vol. 17, no. 12, pp. 1037–1044, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. J. U. Holle, M. Windmöller, C. Lange, W. L. Gross, K. Herlyn, and E. Csernok, “Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis,” Rheumatology, vol. 52, no. 7, pp. 1183–1189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. W. W. Chatham, A. Turkiewicz, and W. D. Blackburn Jr., “Determinants of neutrophil HOCl generation: ligand-dependent responses and the role of surface adhesion,” Journal of Leukocyte Biology, vol. 56, no. 5, pp. 654–660, 1994. View at Google Scholar · View at Scopus
  25. B. J. Bentwood and P. M. Henson, “The sequential release of granule constituents from human neutrophils,” Journal of Immunology, vol. 124, no. 2, pp. 855–862, 1980. View at Google Scholar · View at Scopus
  26. K. Kessenbrock, M. Krumbholz, U. Schönermarck et al., “Netting neutrophils in autoimmune small-vessel vasculitis,” Nature Medicine, vol. 15, no. 6, pp. 623–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Fliss, “Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants,” Molecular and Cellular Biochemistry, vol. 84, no. 2, pp. 177–188, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Winterbourn, “Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid,” Toxicology, vol. 181-182, pp. 223–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. D. T. Harwood, A. J. Kettle, S. Brennan, and C. C. Winterbourn, “Simultaneous determination of reduced glutathione, glutathione disulphide and glutathione sulphonamide in cells and physiological fluids by isotope dilution liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 28, pp. 3393–3399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. D. T. Harwood, A. J. Kettle, and C. C. Winterbourn, “Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC-MS/MS method,” Biochemical Journal, vol. 399, no. 1, pp. 161–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. D. B. Learn, V. A. Fried, and E. L. Thomas, “Taurine and hypotaurine content of human leukocytes,” Journal of Leukocyte Biology, vol. 48, no. 2, pp. 174–182, 1990. View at Google Scholar · View at Scopus
  32. S. J. Klebanoff, A. J. Kettle, H. Rosen, C. C. Winterbourn, and W. M. Nauseef, “Myeloperoxidase: a front-line defender against phagocytosed microorganisms,” Journal of Leukocyte Biology, vol. 93, no. 2, pp. 185–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Aratani, H. Koyama, S.-I. Nyui, K. Suzuki, F. Kura, and N. Maeda, “Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase,” Infection and Immunity, vol. 67, no. 4, pp. 1828–1836, 1999. View at Google Scholar · View at Scopus
  34. Y. Aratani, F. Kura, H. Watanabe et al., “Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase,” Journal of Infectious Diseases, vol. 182, no. 4, pp. 1276–1279, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Brovkovych, X.-P. Gao, E. Ong et al., “Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 295, no. 1, pp. L96–L103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Bruns, O. Kniemeyer, M. Hasenberg et al., “Production of extracellular traps against aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin roda,” PLoS Pathogens, vol. 6, no. 4, Article ID e1000873, 2010. View at Google Scholar · View at Scopus
  37. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. K. D. Metzler, T. A. Fuchs, W. M. Nauseef et al., “Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity,” Blood, vol. 117, no. 3, pp. 953–959, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Parker, A. M. Albrett, A. J. Kettle, and C. C. Winterbourn, “Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide,” Journal of Leukocyte Biology, vol. 91, no. 3, pp. 369–376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Papayannopoulos, K. D. Metzler, A. Hakkim, and A. Zychlinsky, “Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps,” Journal of Cell Biology, vol. 191, no. 3, pp. 677–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R. S. Keshari, A. Jyoti, M. Dubey et al., “Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition,” PLoS ONE, vol. 7, no. 10, Article ID e48111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. K. D. Metzler, C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos, “A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis,” Cell Reports, vol. 8, no. 3, pp. 883–896, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Parker, M. Dragunow, M. B. Hampton, A. J. Kettle, and C. C. Winterbourn, “Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus,” Journal of Leukocyte Biology, vol. 92, no. 4, pp. 841–849, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Akong-Moore, O. A. Chow, M. von Köckritz-Blickwede, and V. Nizet, “Influences of chloride and hypochlorite on neutrophil extracellular trap formation,” PLoS ONE, vol. 7, no. 8, Article ID e42984, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Friedrichs, S. Baldus, and A. Klinke, “Fibrosis in atrial fibrillation—role of reactive species and MPO,” Frontiers in Physiology, vol. 3, article 214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. P. P. Bradley, R. D. Christensen, and G. Rothstein, “Cellular and extracellular myeloperoxidase in pyogenic inflammation,” Blood, vol. 60, no. 3, pp. 618–622, 1982. View at Google Scholar · View at Scopus
  47. A. J. Kettle, T. Chan, I. Osberg et al., “Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 12, pp. 1317–1323, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Malle, C. Woenckhaus, G. Waeg, H. Esterbauer, E. F. Gröne, and H.-J. Gröne, “Immunological evidence for hypochlorite-modified proteins in human kidney,” The American Journal of Pathology, vol. 150, no. 2, pp. 603–615, 1997. View at Google Scholar · View at Scopus
  49. L. K. Stamp, I. Khalilova, J. M. Tarr et al., “Myeloperoxidase and oxidative stress in rheumatoid arthritis,” Rheumatology, vol. 51, no. 10, Article ID kes193, pp. 1796–1803, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. R. J. Johnson, W. G. Couser, E. Y. Chi, S. Adler, and S. J. Klebanoff, “New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system,” The Journal of Clinical Investigation, vol. 79, no. 5, pp. 1379–1387, 1987. View at Publisher · View at Google Scholar · View at Scopus
  51. R. J. Johnson, S. J. Klebanoff, R. F. Ochi et al., “Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis,” Kidney International, vol. 32, no. 3, pp. 342–349, 1987. View at Publisher · View at Google Scholar · View at Scopus
  52. D. L. Lefkowitz, M. P. Gelderman, S. R. Fuhrmann et al., “Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis,” Clinical Immunology, vol. 91, no. 2, pp. 145–155, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Lehners, S. Lange, G. Niemann et al., “Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice,” American Journal of Physiology—Renal Physiology, vol. 307, no. 4, pp. F407–F417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. R. A. Matthijsen, D. Huugen, N. T. Hoebers et al., “Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion,” The American Journal of Pathology, vol. 171, no. 6, pp. 1743–1752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. T. S. McMillen, J. W. Heinecke, and R. C. LeBoeuf, “Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice,” Circulation, vol. 111, no. 21, pp. 2798–2804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Odobasic, A. R. Kitching, T. J. Semple, and S. R. Holdsworth, “Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 18, no. 3, pp. 760–770, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Odobasic, Y. Yang, R. C. M. Muljadi et al., “Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis,” Arthritis and Rheumatology, vol. 66, no. 4, pp. 907–917, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Rudolph, R. P. Andrié, T. K. Rudolph et al., “Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation,” Nature Medicine, vol. 16, no. 4, pp. 470–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Villanueva, S. Yalavarthi, C. C. Berthier et al., “Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus,” Journal of Immunology, vol. 187, no. 1, pp. 538–552, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Warnatsch, M. Ioannou, Q. Wang, and V. Papayannopoulos, “Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis,” Science, vol. 349, no. 6245, pp. 316–320, 2015. View at Publisher · View at Google Scholar
  61. B. Shao, C. Tang, A. Sinha et al., “Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase,” Circulation Research, vol. 114, no. 11, pp. 1733–1742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. C. K. Smith, A. Vivekanandan-Giri, C. Tang et al., “Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus,” Arthritis and Rheumatology, vol. 66, no. 9, pp. 2532–2544, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Khandpur, C. Carmona-Rivera, A. Vivekanandan-Giri et al., “NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis,” Science Translational Medicine, vol. 5, no. 178, Article ID 178ra40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. S. M. Flint, E. F. McKinney, and K. G. C. Smith, “Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis,” Current Opinion in Rheumatology, vol. 27, no. 2, pp. 197–203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. M. A. Cunningham, X. R. Huang, J. P. Dowling, P. G. Tipping, and S. R. Holdsworth, “Prominence of cell-mediated immunity effectors in ‘pauci-immune’ glomerulonephritis,” Journal of the American Society of Nephrology, vol. 10, no. 3, pp. 499–506, 1999. View at Google Scholar · View at Scopus
  66. A. M. Coughlan, S. J. Freeley, and M. G. Robson, “Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis,” Clinical and Experimental Immunology, vol. 169, no. 3, pp. 229–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. P.-Y. Gan, S. R. Holdsworth, A. R. Kitching, and J. D. Ooi, “Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis,” Cellular Immunology, vol. 282, no. 1, pp. 21–27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Kettritz, “How anti-neutrophil cytoplasmic autoantibodies activate neutrophils,” Clinical and Experimental Immunology, vol. 169, no. 3, pp. 220–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. A.-J. Ruth, A. R. Kitching, R. Y. Q. Kwan et al., “Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 1940–1949, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Xiao, P. Heeringa, P. Hu et al., “Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice,” Journal of Clinical Investigation, vol. 110, no. 7, pp. 955–963, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Harper, D. Radford, T. Plant, M. Drayson, D. Adu, and C. O. S. Savage, “IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients,” Arthritis & Rheumatism, vol. 44, no. 4, pp. 921–930, 2001. View at Google Scholar · View at Scopus
  72. J. D. Ooi, J. Chang, M. J. Hickey et al., “The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 39, pp. E2615–E2624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Sangaletti, C. Tripodo, C. Chiodoni et al., “Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity,” Blood, vol. 120, no. 15, pp. 3007–3018, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. A. J. Roth, J. D. Ooi, J. J. Hess et al., “Epitope specificity determines pathogenicity and detectability in anca-associated vasculitis,” Journal of Clinical Investigation, vol. 123, no. 4, pp. 1773–1783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. M. P. Kuligowski, R. Y. Q. Kwan, C. Lo et al., “Antimyeloperoxidase antibodies rapidly induce α4-integrin-dependent glomerular neutrophil adhesion,” Blood, vol. 113, no. 25, pp. 6485–6494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Xiao, P. Heeringa, P. Hu et al., “Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice,” Journal of Clinical Investigation, vol. 110, no. 7, pp. 955–963, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Goldwich, M. Burkard, M. Ölke et al., “Podocytes are nonhematopoietic professional antigen-presenting cells,” Journal of the American Society of Nephrology, vol. 24, no. 6, pp. 906–916, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Iking-Konert, S. Vogt, M. Radsak, C. Wagner, G. M. Hänsch, and K. Andrassy, “Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells,” Kidney International, vol. 60, no. 6, pp. 2247–2262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. P. A. Knolle, T. Germann, U. Treichel et al., “Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells,” Journal of Immunology, vol. 162, no. 3, pp. 1401–1407, 1999. View at Google Scholar · View at Scopus
  80. D. V. Ostanin, E. Kurmaeva, K. Furr et al., “Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis,” Journal of Immunology, vol. 188, no. 3, pp. 1491–1502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. A.-K. Tide, T. Sjögren, M. Svensson et al., “2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation,” The Journal of Biological Chemistry, vol. 286, no. 43, pp. 37578–37589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. W. Zheng, R. Warner, R. Ruggeri et al., “PF-1355, A mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis,” Journal of Pharmacology and Experimental Therapeutics, vol. 353, no. 2, pp. 288–298, 2015. View at Publisher · View at Google Scholar
  83. C. Liu, R. Desikan, Z. Ying et al., “Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model,” PLoS ONE, vol. 7, no. 12, Article ID e50767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Lau, H. Mollnau, J. P. Eiserich et al., “Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 2, pp. 431–436, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. D. El Kebir, L. József, W. Pan, and J. G. Filep, “Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation,” Circulation Research, vol. 103, no. 4, pp. 352–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. M. W. Johansson, M. Patarroyo, F. Oberg, A. Siegbahn, and K. Nilsson, “Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18),” Journal of Cell Science, vol. 110, part 9, pp. 1133–1139, 1997. View at Google Scholar
  87. K. Grattendick, R. Stuart, E. Roberts et al., “Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 6, pp. 716–722, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. D. L. Lefkowitz, E. Roberts, K. Grattendick et al., “The endothelium and cytokine secretion: the role of peroxidases as immunoregulators,” Cellular Immunology, vol. 202, no. 1, pp. 23–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Bennouna, S. K. Bliss, T. J. Curiel, and E. Y. Denkers, “Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection,” The Journal of Immunology, vol. 171, no. 11, pp. 6052–6058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Bennouna and E. Y. Denkers, “Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production,” The Journal of Immunology, vol. 174, no. 8, pp. 4845–4851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. F. C. Weber, T. Németh, J. Z. Csepregi et al., “Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity,” Journal of Experimental Medicine, vol. 212, no. 1, pp. 15–22, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. H. R. Hampton, J. Bailey, M. Tomura, R. Brink, and T. Chtanova, “Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes,” Nature Communications, vol. 6, article 7139, 2015. View at Publisher · View at Google Scholar
  93. C. Beauvillain, P. Cunin, A. Doni et al., “CCR7 is involved in the migration of neutrophils to lymph nodes,” Blood, vol. 117, no. 4, pp. 1196–1204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. C. V. Gorlino, R. P. Ranocchia, M. F. Harman et al., “Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes,” The Journal of Immunology, vol. 193, no. 4, pp. 1966–1974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Pillay, V. M. Kamp, E. Van Hoffen et al., “A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1,” Journal of Clinical Investigation, vol. 122, no. 1, pp. 327–336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Odobasic, R. C. Muljadi, K. M. O'Sullivan et al., “Suppression of autoimmunity and renal disease in pristane-induced lupus by myeloperoxidase,” Arthritis & Rheumatology, vol. 67, no. 7, pp. 1868–1880, 2015. View at Publisher · View at Google Scholar
  97. V. Abadie, E. Badell, P. Douillard et al., “Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes,” Blood, vol. 106, no. 5, pp. 1843–1850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Marcinkiewicz, B. Nowak, A. Grabowska, M. Bobek, L. Petrovska, and B. Chain, “Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system,” Immunology, vol. 98, no. 3, pp. 371–378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. C. L. Hawkins, “The role of hypothiocyanous acid (HOSCN) in biological systems,” Free Radical Research, vol. 43, no. 12, pp. 1147–1158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Xiong, C. Zhu, F. Li et al., “Inhibition of interleukin-12 p40 transcription and NF-κB activation by nitric oxide in murine macrophages and dendritic cells,” Journal of Biological Chemistry, vol. 279, no. 11, pp. 10776–10783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. E. M. Behrens, U. Sriram, D. K. Shivers et al., “Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity,” The Journal of Immunology, vol. 178, no. 10, pp. 6268–6279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Blouin, L. Halbwachs-Mecarelli, and P. Rieu, “Redox regulation of β2-integrin CD11b/CD18 activation,” European Journal of Immunology, vol. 29, no. 11, pp. 3419–3431, 1999. View at Google Scholar · View at Scopus
  103. T. K. Nowling and G. S. Gilkeson, “Mechanisms of tissue injury in lupus nephritis,” Arthritis Research and Therapy, vol. 13, no. 6, article 250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. W. H. Reeves, P. Y. Lee, J. S. Weinstein, M. Satoh, and L. Lu, “Induction of autoimmunity by pristane and other naturally occurring hydrocarbons,” Trends in Immunology, vol. 30, no. 9, pp. 455–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. H. Bouali, P. Nietert, T. M. Nowling et al., “Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus,” Journal of Rheumatology, vol. 34, no. 10, pp. 2028–2034, 2007. View at Google Scholar · View at Scopus
  106. D. Pohlers, K. Nissler, O. Frey et al., “Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation,” Clinical and Experimental Immunology, vol. 135, no. 3, pp. 409–415, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Kutter, P. Devaquet, G. Vanderstocken, J. M. Paulus, V. Marchal, and A. Gothot, “Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ?” Acta Haematologica, vol. 104, no. 1, pp. 10–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. M. P. Kuligowski, A. R. Kitching, and M. J. Hickey, “Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling,” Journal of Immunology, vol. 176, no. 11, pp. 6991–6999, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. X. R. Huang, S. R. Holdsworth, and P. G. Tipping, “Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation,” Kidney International, vol. 46, no. 1, pp. 69–78, 1994. View at Publisher · View at Google Scholar · View at Scopus
  110. P. G. Tipping, X. R. Huang, M. Qi, G. Y. Van, and W. W. Tang, “Crescentic glomerulonephritis in CD4- and CD8-deficient mice: requirement for CD4 but not CD8 cells,” The American Journal of Pathology, vol. 152, no. 6, pp. 1541–1548, 1998. View at Google Scholar · View at Scopus
  111. J. L. Eyles, M. J. Hickey, M. U. Norman et al., “A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis,” Blood, vol. 112, no. 13, pp. 5193–5201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. C. Mauri, C.-Q. Q. Chu, D. Woodrow, L. Mori, and M. Londei, “Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody,” The Journal of Immunology, vol. 159, no. 10, pp. 5032–5041, 1997. View at Google Scholar · View at Scopus
  113. L. Svensson, J. Jirholt, R. Holmdahl, and L. Jansson, “B cell-deficient mice do not develop type II collagen-induced arthritis (CIA),” Clinical and Experimental Immunology, vol. 111, no. 3, pp. 521–526, 1998. View at Publisher · View at Google Scholar · View at Scopus
  114. B. T. Wipke and P. M. Allen, “Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis,” The Journal of Immunology, vol. 167, no. 3, pp. 1601–1608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  115. R. Cramer, M. R. Soranzo, and P. Dri, “Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies,” British Journal of Haematology, vol. 51, no. 1, pp. 81–87, 1982. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Kitahara, H. J. Eyre, Y. Simonian, C. L. Atkin, and S. J. Hasstedt, “Hereditary myeloperoxidase deficiency,” Blood, vol. 57, no. 5, pp. 888–893, 1981. View at Google Scholar · View at Scopus
  117. C. Larrocha, M. Fernandez de Castro, G. Fontan, A. Viloria, J. L. Fernández-Chacón, and C. Jiménez, “Hereditary myeloperoxidase deficiency: study of 12 cases,” Scandinavian Journal of Haematology, vol. 29, no. 5, pp. 389–397, 1982. View at Google Scholar · View at Scopus
  118. M. F. Parry, R. K. Root, J. A. Metcalf, K. K. Delaney, L. S. Kaplow, and W. J. Richar, “Myeloperoxidase deficiency: prevalence and clinical significance,” Annals of Internal Medicine, vol. 95, no. 3, pp. 293–301, 1981. View at Publisher · View at Google Scholar · View at Scopus
  119. R. I. Lehrer and M. J. Cline, “Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection,” Journal of Clinical Investigation, vol. 48, no. 8, pp. 1478–1488, 1969. View at Publisher · View at Google Scholar · View at Scopus
  120. C. Nguyen and H. P. Katner, “Myeloperoxidase deficiency manifesting as pustular candidal dermatitis,” Clinical Infectious Diseases, vol. 24, no. 2, pp. 258–260, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. D. Kutter, “Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology,” Journal of Molecular Medicine, vol. 76, no. 10, pp. 669–675, 1998. View at Publisher · View at Google Scholar · View at Scopus
  122. T. O. Hirche, J. P. Gaut, J. W. Heinecke, and A. Belaaouaj, “Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense,” The Journal of Immunology, vol. 174, no. 3, pp. 1557–1565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. B. Korkmaz, T. Moreau, and F. Gauthier, “Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions,” Biochimie, vol. 90, no. 2, pp. 227–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  124. B. Shao, A. Belaaouaj, C. L. M. J. Verlinde, X. Fu, and J. W. Heinecke, “Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidase,” Journal of Biological Chemistry, vol. 280, no. 32, pp. 29311–29321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. P. Dri, R. Cramer, R. Menegazzi, and P. Patriarca, “Increased degranulation of human myeloperoxidase-deficient polymorphonuclear leucocytes,” British Journal of Haematology, vol. 59, no. 1, pp. 115–125, 1985. View at Publisher · View at Google Scholar · View at Scopus
  126. O. Stendahl, B. I. Coble, C. Dahlgren, J. Hed, and L. Molin, “Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient,” The Journal of Clinical Investigation, vol. 73, no. 2, pp. 366–373, 1984. View at Publisher · View at Google Scholar · View at Scopus
  127. G. Ramsaransing, A. Teelken, V. M. Prokopenko, A. V. Arutjunyan, and J. De Keyser, “Low leucocyte myeloperoxidase activity in patients with multiple sclerosis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 7, pp. 953–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Uchimura, A. Nagasaka, R. Hayashi et al., “Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus,” Journal of Diabetes and its Complications, vol. 13, no. 5-6, pp. 264–270, 1999. View at Publisher · View at Google Scholar · View at Scopus